Latest Acute myeloid leukemia Stories
Data from 13 accepted abstracts include: NORTH CHICAGO, Ill., Nov.
Live Webcast from New York on November 19th SAN DIEGO, Nov. 12, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND
BERGEN, Norway, November 4, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the first patient
Comprehensive Cancer Diagnostic Report to include clinical data, FDA approved therapies MILWAUKEE, Oct.
AMSTERDAM, October 30, 2014 /PRNewswire/ -- Kiadis Pharma B.V.
This Year Marks the 20th Anniversary of LLS's Prestigious Translational Research Program WHITE PLAINS, N.Y., Oct.
The Program is Jointly Funded by LLS and Janssen Research & Development, LLC WHITE PLAINS, N.Y., Oct.
- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - SEATTLE, Oct. 27, 2014 /PRNewswire/ -- CTI BioPharma Corp.
WHITE PLAINS, N.Y., Oct.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.